São Paulo, June 2021 – Eurofarma, a pharmaceutical company with operations in 20 Latin American countries, strengthens its presence in Colombia with the acquisition of six drugs from pharmaceutical company Grünenthal: Acibogel (Simeticone), for stomach malaise, Fazol (Ketoconazole), for the treatment of dermatomycosis, Pilogam (topical Minoxidil), for the treatment of hair loss, Valcyclor (Valaciclovir) and Virex (Aciclovir), both for the treatment of herpes, and Stopen (Piroxicam), an anti-inflammatory medication for the relief of arthrosis symptoms.

The acquisitions expand Eurofarma’s portfolio in the country, which already includes products in different therapeutic classes and segments. The transaction reaffirms the company’s commitment to continue speeding up the growth of its international operations, especially in Colombia, one of the main markets in the region. Most of the products were already manufactured at the Eurofarma Colombia plant.

Present in Colombia since 2012, this new acquisition by the company is aligned with the challenge of consolidating operations in Latin America, and growing through acquisitions. The goal highlighted in Eurofarma’s 2022 Vision establishes that international operations will account for 30% of the company’s total revenue. 

About Eurofarma Group 

As the first multinational pharmaceutical enterprise with 100% Brazilian capital, the Eurofarma Group has been operating in the pharmaceutical industry since its establishment in 1972, producing and marketing innovative healthcare products and services to improve people’s quality of life. A very diversified company, Eurofarma operates in all major segments, such as Prescription, Non-Prescription, Generic, Hospital, Oncology, and Veterinary Drugs. In Brazil alone, it offers more than 430 products in over 1,000 SKUs, serves all medical specialties, and covers upwards of 200 therapeutic classes, accounting for 80% of the total market.

The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in six more Latin American countries. Reported net sales totaled BRL 5.7 billion in 2020 and the Group employs over 7,600 people.

Eurofarma in social media
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarma | Twitter: @eurofarma
Youtube: @eurofarmalab